Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva launches Indoco Remedies-developed generic drug in US - The Economic Times
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Teva Pharmaceuticals
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
Teva pharmaceutical industries limited
Teva Pharmaceuticals | LinkedIn
An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Teva's Key Drugs in Its Specialty Products Pipeline
ELMIRON LITIGATION: EMERGING TORTS - Mass Tort News
Top five generic drug makers
Teva unifies pharmaceutical packaging worldwide | packagingdigest.com
Teva Pharmaceuticals - Wikipedia
Teva looks to amp up research collaborations, CEO says
Teva Pharmaceuticals: Making Quality Health Care Accessible
Amicus' Acquiescence To Teva's Drug Supply Request Reflects Power Of CREATES Act :: Pink Sheet
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Pharmaceutical Industries Ltd. | Global Philadelphia Association
Teva Pharmaceuticals Acquisition – PL Developments
Teva USA
